Coronavirus Update: Hardest Hit US States Will Test Moderna’s Vaccine

Plus: Merck 's Frazier Criticizes Vaccine Hype

A round-up of developments in the COVID-19 vaccine field from Moderna, Fosun, Merck & Co and Medicago and more.  

Florida_Pool
Florida has become the new epicenter of infections in the US, averaging nearly 10,000 new cases per day for the last week.

Moderna, Inc. is to begin Phase III trials of its COVID-19 vaccine very soon, and the newly revealed study protocol shows it will target US states hardest hit by the pandemic to generate its make-or-break results.

The US biotech is a frontrunner in the race to develop a vaccine against the novel coronavirus, and is aiming...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip